[go: up one dir, main page]

WO2007049304A3 - Formulation pharmaceutique enrobee, stable, d'olanzapine et son procede de preparation - Google Patents

Formulation pharmaceutique enrobee, stable, d'olanzapine et son procede de preparation Download PDF

Info

Publication number
WO2007049304A3
WO2007049304A3 PCT/IN2006/000430 IN2006000430W WO2007049304A3 WO 2007049304 A3 WO2007049304 A3 WO 2007049304A3 IN 2006000430 W IN2006000430 W IN 2006000430W WO 2007049304 A3 WO2007049304 A3 WO 2007049304A3
Authority
WO
WIPO (PCT)
Prior art keywords
olanzapine
preparing
same
pharmaceutical formulation
formulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IN2006/000430
Other languages
English (en)
Other versions
WO2007049304A2 (fr
Inventor
Pavak Mehta
Piyush Gupta
Rajesh Bhaskar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jubilant Organosys Ltd
Original Assignee
Jubilant Organosys Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jubilant Organosys Ltd filed Critical Jubilant Organosys Ltd
Publication of WO2007049304A2 publication Critical patent/WO2007049304A2/fr
Publication of WO2007049304A3 publication Critical patent/WO2007049304A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/282—Organic compounds, e.g. fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'invention concerne des formulations orales enrobées, solides, stables, d'olanzapine et leur procédé de préparation. La formulation comprend une quantité efficace d'olanzapine et un excipient acceptable d'un point de vue pharmaceutique. L'enrobage stabilisé de la formulation utilise un polymère sélectif sélectionné parmi un phtalate d'hydroxypropylméthylcellulose, un phtalate d'acétate de polyvinyle, un phtalate d'acétate de cellulose, un succinate d'acétate d'hydroxypropylméthylcellulose, un alcool polyvinylique, un copolymère d'acétate de vinyle, une gomme ou zéine obtenue à partir du pullulane ou une combinaison de celles-ci.
PCT/IN2006/000430 2005-10-27 2006-10-27 Formulation pharmaceutique enrobee, stable, d'olanzapine et son procede de preparation Ceased WO2007049304A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN2880DE2005 2005-10-27
IN2880/DEL/2005 2005-10-27

Publications (2)

Publication Number Publication Date
WO2007049304A2 WO2007049304A2 (fr) 2007-05-03
WO2007049304A3 true WO2007049304A3 (fr) 2007-07-26

Family

ID=37894365

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IN2006/000430 Ceased WO2007049304A2 (fr) 2005-10-27 2006-10-27 Formulation pharmaceutique enrobee, stable, d'olanzapine et son procede de preparation

Country Status (1)

Country Link
WO (1) WO2007049304A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012153347A2 (fr) * 2011-05-04 2012-11-15 Zentiva K.S. Composition pharmaceutique d'olanzapine de forme 1 à administration par voie orale

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0830858A1 (fr) * 1996-09-24 1998-03-25 Eli Lilly And Company Formulation contenant des particules d'olanzapine revêtues
US5919485A (en) * 1995-03-24 1999-07-06 Eli Lilly And Company Oral 2-methyl-thieno-benzodiazepine formulation
WO2001037816A2 (fr) * 1999-11-23 2001-05-31 Biochemie Gesellschaft M.B.H. Enrobage
WO2004058222A1 (fr) * 2002-12-20 2004-07-15 St. James Associates Llc/Faber Research Series Compactage haute pression pour formulations pharmaceutiques
WO2005009407A2 (fr) * 2003-07-29 2005-02-03 Ranbaxy Laboratories Limited Formulations pharmaceutiques d'olanzapine administrees par voie orale

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5919485A (en) * 1995-03-24 1999-07-06 Eli Lilly And Company Oral 2-methyl-thieno-benzodiazepine formulation
EP0830858A1 (fr) * 1996-09-24 1998-03-25 Eli Lilly And Company Formulation contenant des particules d'olanzapine revêtues
WO2001037816A2 (fr) * 1999-11-23 2001-05-31 Biochemie Gesellschaft M.B.H. Enrobage
WO2004058222A1 (fr) * 2002-12-20 2004-07-15 St. James Associates Llc/Faber Research Series Compactage haute pression pour formulations pharmaceutiques
WO2005009407A2 (fr) * 2003-07-29 2005-02-03 Ranbaxy Laboratories Limited Formulations pharmaceutiques d'olanzapine administrees par voie orale

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
ANON.: "Oral pharmaceutical formulations for antipsychotic agent", IP.COM, vol. 3, no. 4, 2003, pages 60 - 61, XP013005932 *

Also Published As

Publication number Publication date
WO2007049304A2 (fr) 2007-05-03

Similar Documents

Publication Publication Date Title
TWI354569B (en) Coated tablet formulation and method
WO2001052816A3 (fr) Formulations pharmaceutiques de derives benzimidazole administrees par voie orale et procede de preparation de ces dernieres
WO2006124366A3 (fr) Aromatisant pour chewing gums contenant un medicament
WO2007139886A3 (fr) Formulations à libération retardée de chlorhydrate de duloxétine
WO2005007139A3 (fr) Forme galenique multiparticulaire contenant des principes actifs peptidiques ou proteiques formules de façon a presenter une action mucoadhesive, et procede de production de cette forme galenique
WO2001022791A3 (fr) Compositions a liberation regulee contenant de la nimesulide
WO2003066030A3 (fr) Comprimé pharmaceutique
NO325073B1 (no) Preparat for anvendelse i munnhulen med en film eller sjikt som viser oyeblikkelig fuktbarhet.
JP2009510068A5 (fr)
NZ709754A (en) Taste-masked pharmaceutical compositions with gastrosoluble pore-formers
WO2008000731A3 (fr) Composition pharmaceutique destinée à l'administration par voie orale d'acides gras polyinsaturés oméga et d'au moins un principe actif incompatible avec eux, et procédé de préparation de celle-ci
JP2011506384A (ja) マルチゾーンフィルム
JP2002275053A (ja) 医薬錠剤及びその製造のための方法
WO2008006795A3 (fr) Composés d'indole
KR101643572B1 (ko) 고함량의 약물을 함유하는 구강 붕해 필름 및 이의 제조방법
WO2004100883A3 (fr) Procede de preparation de compositions thermoformees contenant des liants de polymere acrylique, des posologies pharmaceutiques et leurs procedes de preparation
WO2006115712A3 (fr) Films cellulosiques renfermant un plastifiant acceptable sur le plan pharmaceutique a mouillabilite amelioree
WO2004062552A3 (fr) Composition pharmaceutique contenant un ains et un derive benzimidazole
WO2007049304A3 (fr) Formulation pharmaceutique enrobee, stable, d'olanzapine et son procede de preparation
WO2007025182A3 (fr) Compositions de medicament renfermant des matrices d'hypermellose a liberation commandee
WO2010018175A3 (fr) Formulation pharmaceutique orale pour l’oméprazole comprenant une couche de séparation spécifique
JP2010521437A5 (fr)
TW200700063A (en) Oral dosage form comprising 5-[4-[2-(n-methyl-n-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione
CA2566931A1 (fr) Comprimes presentant une variabilite reduite de liberation de medicament
WO2009014372A3 (fr) Comprimé dispersible comprenant des particules enrobées contenant un médicament et procédé de préparation correspondant

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 06809971

Country of ref document: EP

Kind code of ref document: A2